52764 Federal Register / Vol. 75, No. 166 / Friday, August 27, 2010 / Notices 

form of identification (for example, a 

government-issued photo ID, driver’s license, 

or passport) and to state the purpose of their 

visit. 

(Catalogue of Federal Domestic Assistance 

Program Nos. 93.847, Diabetes, 

Endocrinology and Metabolic Research; 

93.848, Digestive Diseases and Nutrition 

Research; 93.849, Kidney Diseases, Urology 

and Hematology Research, National Institutes 

of Health, HHS) 

Dated: August 23, 2010. 

Jennifer S. Spaeth, 

Director, Office of Federal Advisory 

Committee Policy. 

[FR Doc. 2010–21362 Filed 8–26–10; 8:45 am] 

BILLING CODE 4140–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

Center for Scientific Review; Notice of 

Closed Meetings 

Pursuant to section 10(d) of the 

Federal Advisory Committee Act, as 

amended (5 U.S.C. App.), notice is 

hereby given of the following meetings. 

The meetings will be closed to the 

public in accordance with the 

provisions set forth in sections 

552b(c)(4) and 552b(c)(6), Title 5 U.S.C., 

as amended. The grant applications and 

the discussions could disclose 

confidential trade secrets or commercial 

property such as patentable material, 

and personal information concerning 

individuals associated with the grant 

applications, the disclosure of which 

would constitute a clearly unwarranted 

invasion of personal privacy. 

Name of Committee: Center for Scientific 

Review Special Emphasis Panel, Member 

Conflict: Topics in Aging. 

Date: September 23, 2010. 

Time: 1 p.m. to 3 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 6701 

Rockledge Drive, Bethesda, MD 20892. 

(Telephone Conference Call.) 

Contact Person: John Burch, PhD, 

Scientific Review Officer, Center for 

Scientific Review, National Institute of 

Health, 6701 Rockledge Drive, Room 3213, 

MSC 7808, Bethesda, MD 20892. 301–408– 

9519. burchjb@csr.nih.gov. 

Name of Committee: Center for Scientific 

Review Special Emphasis Panel, 

Neurological, Neuroimmune Disorders and 

Plasticity. 

Date: September 27–28, 2010. 

Time: 8 a.m. to 5 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 6701 

Rockledge Drive, Bethesda, MD 20892. 

(Virtual Meeting.) 

Contact Person: Julius Cinque, MS, 

Scientific Review Officer, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 5186, 

MSC 7846, Bethesda, MD 20892. (301) 435– 

1252. cinquej@csr.nih.gov. 

Name of Committee: Oncology 2— 

Translational Clinical Integrated Review 

Group, Drug Discovery and Molecular 

Pharmacology Study Section. 

Date: September 27–28, 2010. 

Time: 8 a.m. to 5 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: Embassy Suites at the Chevy Chase 

Pavilion, 4300 Military Road, NW., 

Washington, DC 20015. 

Contact Person: Hungyi Shau, PhD, 

Scientific Review Officer, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 6214, 

MSC 7804, Bethesda, MD 20892. 301–435– 

1720. shauhung@csr.nih.gov. 

Name of Committee: Surgical Sciences, 

Biomedical Imaging and Bioengineering 

Integrated Review Group, Biomedical 

Imaging Technology Study Section. 

Date: October 4–5, 2010. 

Time: 8 a.m. to 5 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: Hilton Washington/Rockville, 1750 

Rockville Pike, Rockville, MD 20852. 

Contact Person: Lee Rosen, PhD, Scientific 

Review Officer, Center for Scientific Review, 

National Institutes of Health, 6701 Rockledge 

Drive, Room 5116, MSC 7854, Bethesda, MD 

20892. (301) 435–1171. rosenl@csr.nih.gov. 

Name of Committee: Endocrinology, 

Metabolism, Nutrition and Reproductive 

Sciences Integrated Review Group, Molecular 

and Cellular Endocrinology Study Section. 

Date: October 6, 2010. 

Time: 7 a.m. to 6 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: Sheraton Bellevue Hotel, 100 112th 

Avenue, NE., Bellevue, WA 98004. 

Contact Person: Robert Garofalo, PhD, 

Scientific Review Officer, Center for 

Scientific Review, National Institute of 

Health, 6701 Rockledge Drive, Room 6156, 

MSC 7892, Bethesda, MD 20892. 301–435– 

1043. garofalors@csr.nih.gov. 

Name of Committee: Population Sciences 

and Epidemiology Integrated Review Group, 

Epidemiology of Cancer Study Section. 

Date: October 6–7, 2010. 

Time: 7:30 a.m. to 3 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: Avenue Hotel Chicago, 160 E. Huron 

Street, Chicago, IL 60611. 

Contact Person: Denise Wiesch, PhD, 

Scientific Review Officer, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 3150, 

MSC 7770, Bethesda, MD 20892. (301) 435– 

0684. wieschd@csr.nih.gov. 

Name of Committee: Integrative, 

Functional and Cognitive Neuroscience 

Integrated Review Group, Neurobiology of 

Motivated Behavior Study Section. 

Date: October 6, 2010. 

Time: 8 a.m. to 5 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: Embassy Suites at the Chevy Chase 

Pavilion, 4300 Military Road, NW., 

Washington, DC 20015. 

Contact Person: Edwin C Clayton, PhD, 

Scientific Review Officer, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 5180, 

MSC 7844, Bethesda, MD 20892. 301–408– 

9041. claytone@csr.nih.gov. 

Name of Committee: Integrative, 

Functional and Cognitive Neuroscience 

Integrated Review Group, Central Visual 

Processing Study Section. 

Date: October 6, 2010. 

Time: 8 a.m. to 5 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: Doubletree Hotel Bethesda, 8120 

Wisconsin Avenue, Bethesda, MD 20814. 

Contact Person: John Bishop, PhD, 

Scientific Review Officer, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 5182, 

MSC 7844, Bethesda, MD 20892. (301) 408– 

9664. bishopj@csr.nih.gov. 

Name of Committee: Integrative, 

Functional and Cognitive Neuroscience 

Integrated Review Group, Auditory System 

Study Section. 

Date: October 6–7, 2010. 

Time: 8 a.m. to 3 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: Doubletree Hotel Bethesda, 8120 

Wisconsin Avenue, Bethesda, MD 20814. 

Contact Person: Lynn E Luethke, PhD, 

Scientific Review Officer, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 5166, 

MSC 7844, Bethesda, MD 20892. (301) 806– 

3323. luethkel@csr.nih.gov. 

Name of Committee: Infectious Diseases 

and Microbiology Integrated Review Group, 

Vector Biology Study Section. 

Date: October 6, 2010. 

Time: 8 a.m. to 6:30 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: One Washington Circle Hotel, One 

Washington Circle, NW., Washington, DC 

20037. 

Contact Person: Liangbiao Zheng, PhD, 

Scientific Review Officer, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 3214, 

MSC 7808, Bethesda, MD 20892. 301–402– 

5671. zhengli@csr.nih.gov. 

Name of Committee: Cardiovascular and 

Respiratory Sciences Integrated Review 

Group, Lung Cellular, Molecular, and 

Immunobiology Study Section. 

Date: October 6–7, 2010. 

Time: 8 a.m. to 5 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: The Westin St. Francis, 335 Powell 

Street, San Francisco, CA 94102. 

Contact Person: George M. Barnas, PhD, 

Scientific Review Officer, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 2180, 

MSC 7818, Bethesda, MD 20892. 301–435– 

0696. barnasg@csr.nih.gov. 

Name of Committee: Digestive, Kidney and 

Urological Systems Integrated Review Group, 

WReier-Aviles on DSKGBLS3C1PROD with NOTICES

Federal Register / Vol. 75, No. 166 / Friday, August 27, 2010 / Notices 52765 

Xenobiotic and Nutrient Disposition and 

Action Study Section. 

Date: October 6, 2010. 

Time: 8 a.m. to 6 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: Hyatt Regency Bethesda, One 

Bethesda Metro Center, 7400 Wisconsin 

Avenue, Bethesda, MD 20814. 

Contact Person: Patricia Greenwel, PhD, 

Scientific Review Officer, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 2172, 

MSC 7818, Bethesda, MD 20892. 301–435– 

1169. greenwep@csr.nih.gov. 

Name of Committee: Cardiovascular and 

Respiratory Sciences Integrated Review 

Group, Myocardial Ischemia and Metabolism 

Study Section. 

Date: October 6–7, 2010. 

Time: 8 a.m. to 5 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: The Westin St. Francis, 335 Powell 

Street, San Francisco, CA 94102. 

Contact Person: Joseph Thomas Peterson, 

PhD, Scientific Review Officer, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 4118, 

MSC 7814, Bethesda, MD 20892. 301–443– 

8130. petersonjt@csr.nih.gov. 

Name of Committee: Bioengineering 

Sciences & Technologies Integrated Review 

Group, Gene and Drug Delivery Systems 

Study Section. 

Date: October 6–7, 2010. 

Time: 8 a.m. to 5 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: Hotel Nikko San Francisco, 222 

Mason Street, San Francisco, CA 94102. 

Contact Person: Amy L Rubinstein, PhD, 

Scientific Review Officer, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 5152, 

MSC 7844, Bethesda, MD 20892. 301–408– 

9754. rubinsteinal@csr.nih.gov. 

Name of Committee: Cell Biology 

Integrated Review Group, Molecular and 

Integrative Signal Transduction Study 

Section. 

Date: October 6–7, 2010. 

Time: 8 a.m. to 5:30 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: Sir Francis Drake Hotel, 450 Powell 

Street at Sutter, San Francisco, CA 94102. 

Contact Person: Raya Mandler, PhD, 

Scientific Review Officer, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 5134, 

MSC 7840, Bethesda, MD 20892. (301) 402– 

8228. rayam@csr.nih.gov. 

Name of Committee: Center for Scientific 

Review Special Emphasis Panel, Small 

Business: Neuroscience Education. 

Date: October 6–7, 2010. 

Time: 8:30 a.m. to 5 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 6701 

Rockledge Drive, Bethesda, MD 20892. 

(Virtual Meeting.) 

Contact Person: Jonathan Arias, PhD, 

Scientific Review Officer, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 5170, 

MSC 7840, Bethesda, MD 20892. 301–435– 

2406. ariasj@csr.nih.gov. 

(Catalogue of Federal Domestic Assistance 

Program Nos. 93.306, Comparative Medicine; 

93.333, Clinical Research, 93.306, 93.333, 

93.337, 93.393–93.396, 93.837–93.844, 

93.846–93.878, 93.892, 93.893, National 

Institutes of Health, HHS) 

Dated: August 23, 2010. 

Jennifer S. Spaeth, 

Director, Office of Federal Advisory 

Committee Policy. 

[FR Doc. 2010–21357 Filed 8–26–10; 8:45 am] 

BILLING CODE 4140–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

Center for Scientific Review; Amended 

Notice of Meeting 

Notice is hereby given of a change in 

the meeting of the Molecular Genetics B 

Study Section, October 3, 2010, 7 p.m. 

to October 4, 2010, 8 a.m., The Fairmont 

Hotel, 950 Mason Street, San Francisco, 

CA 94108 which was published in the 

Federal Register on August 19, 2010, 75 

FR 51277–51278. 

The meeting will be held October 4, 

2010, 7 p.m. to October 5, 2010, 6 p.m. 

The meeting location remains the same. 

The meeting is closed to the public. 

Dated: August 19, 2010. 

Jennifer S. Spaeth, 

Director, Office of Federal Advisory 

Committee Policy. 

[FR Doc. 2010–21352 Filed 8–26–10; 8:45 am] 

BILLING CODE 4140–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Food and Drug Administration 

[Docket No. FDA–2010–N–0437] 

Development and Distribution of 

Patient Medication Information for 

Prescription Drugs; Public Hearing 

AGENCY: Food and Drug Administration, 

HHS. 

ACTION: Notice of public hearing; 

request for comment. 

SUMMARY: The Food and Drug 

Administration (FDA) is announcing a 

2-day public hearing to obtain input on 

a new framework for development and 

distribution of patient medication 

information (PMI) to be provided to 

patients who are prescribed drug 

products. Under the current system, 

patients may receive several different 

types of information, developed by 

different sources that may be 

duplicative, incomplete, or difficult to 

read and understand. FDA has 

determined that the current system is 

not adequate to ensure that patients 

receive the essential medication 

information that is needed to use the 

drug safely. Based on recommendations 

from FDA’s Risk Communication 

Advisory Committee (RCAC) and other 

stakeholder input, FDA sees merit in 

adopting use of a single document that 

is standardized with respect to content 

and format. The purpose of this hearing 

is to solicit public input on processes 

and procedures for standardizing PMI 

using a quality system approach for 

monitoring development and 

distribution of PMI. 

DATES: The public hearing will be held 

on September 27 and 28, 2010, from 

8:30 a.m. to 4:30 p.m. Registration 

requests and requests to present at the 

public hearing should be received by 

September 13, 2010 (see section III of 

this document for details). Electronic or 

written comments will be accepted after 

the public hearing until October 29, 

2010 (see section V of this document for 

details). 

ADDRESSES: The public hearing will be 

held at FDA’s White Oak Campus, 

10903 New Hampshire Ave., Bldg. 31, 

rm. 1503, Silver Spring, MD 20993. To 

register for the public hearing, email 

your registration information to 

PMIpublicmeeting@fda.hhs.gov. See 

section III of this document for 

registration details. Submit electronic 

comments to http:// 

www.regulations.gov. Submit written 

comments to the Division of Dockets 

Management (HFA–305), Food and Drug 

Administration, 5630 Fishers Lane, rm. 

1061, Rockville, MD 20852. Identify 

comments with the docket number 

found in brackets in the heading of this 

document. 

FOR FURTHER INFORMATION CONTACT: 

Denise Hinton, Center for Drug 

Evaluation and Research, Food and 

Drug Administration, 10903 New 

Hampshire Ave., Bldg. 51, rm. 6348, 

Silver Spring, MD 20993, 301–796– 

1090, FAX: 301–847–3529, email: 

PMIpublicmeeting@fda.hhs.gov. 

SUPPLEMENTARY INFORMATION: 

I. Background 

Ensuring that patients who are 

prescribed medical products have 

access to quality information about 

those products is an important 

component of medical product safety. 

Currently, patients receive multiple 

types of written prescription drug 

information in varying formats, which 

WReier-Aviles on DSKGBLS3C1PROD with NOTICES